Tenecteplase Reperfusion therapy in Acute ischaemic Cerebrovascular Events-II (TRACE II): rationale and design

BACKGROUND AND PURPOSE: Tenecteplase (TNK) is a promising agent for treatment of acute ischaemic stroke (AIS). We hypothesised that recombinant human TNK tissue-type plasminogen activator (rhTNK-tPA) is non-inferior to rt-PA in achieving excellent functional outcome at 90 days, when administered wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuya, Campbell, Bruce C V, Schwamm, Lee H, Fisher, Marc, Parsons, Mark, Li, Hao, Pan, Yuesong, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899655/
https://www.ncbi.nlm.nih.gov/pubmed/34446531
http://dx.doi.org/10.1136/svn-2021-001074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899655/
https://www.ncbi.nlm.nih.gov/pubmed/34446531
http://dx.doi.org/10.1136/svn-2021-001074

Ejemplares similares